Turn Your Protein Challenges into Your Next Breakthrough In protein science, structure determines function—and every production decision you make shapes that structure. From the molecular…
Category: Uncategorized
Choosing the Right CRO for In Vivo Research
A promising therapeutic candidate eventually reaches a decisive moment: the in vivo study that will shape what happens next. At this stage, choosing a Contract…
Faster from Gene to Protein: Building Confidence into Every Development Decision
In drug discovery and development, critical decisions are only as good as the data supporting them. Whether selecting a lead candidate, validating a therapeutic target,…
Allometric Scaling for Peptides: Myths, Pitfalls, and Predictive Strategies
Peptide therapeutics continue to gain momentum across metabolic disorders, oncology, and other high-value therapeutic areas. However, for sponsors advancing peptide candidates toward the clinic, one…
The World Cup might be over, but FC Aragen is still on the pitch
While the world’s greatest football teams fight for trophies, we play a different kind of championship every day. Our pitch? The drug discovery and development pipeline. …
From Discovery to Drug: The Role of Stable Cell Lines in Peptide Therapeutics
Therapeutic peptides are rapidly reshaping the drug discovery landscape. Combining the target specificity of biologics with many of the development advantages of small molecules, they…
Method Transfer De-Risks in Integrated DS–DP: When and How to Avoid Inter-Site Transfers
Integrated DS–DP programmes are built to eliminate handoff risk—yet inter-site analytical transfers keep appearing. Here is a practical guide for CRDMO teams and their sponsors…
Ensuring Biosafety of Genetically Engineered Crops: Meeting the Standards
Advances in agricultural biotechnology are reshaping the way we grow food. Genetically engineered (GE) crops—ranging from insect-resistant varieties to herbicide-tolerant traits—are helping farmers improve productivity,…
Accelerating Cell Line Development for Biologics and Biosimilars
The biologics and biosimilars industry is booming, driven by the need for innovative therapies and affordable alternatives. But here’s the challenge: While a full Gene-to-GMP…
Comprehensive E-Fate and Metabolism Studies for Agrochemicals and Metabolites
Driving Safe, Sustainable Agrochemical Innovation with INTOX The global agricultural landscape continues to evolve, with increased focus on sustainability, environmental safety, and regulatory compliance. Central…
